GlassScriptPhysician profile
Lin G Lemay
NPI 1871538686
$9,035.97
in general payments reported to CMS, 2019-2025
56 companies · $1,283 in 2025
The $1,283 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,454 · 2020: $813 · 2021: $988 · 2022: $1,020 · 2023: $1,477 · 2024: $2,001 · 2025: $1,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,717 · Education: $43.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,717.46 |
| Education | $43.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,276.39 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $603.78 | 2019-2025 | |
| Neurelis, INC. | $526.65 | 2023-2025 | Valtoco |
| Argenx US, INC. | $371.90 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Biogen, INC. | $350.21 | 2019-2023 | Tysabri, Vumerity |
| Sk Life Science, INC. | $347.53 | 2020-2025 | |
| Supernus Pharmaceuticals, INC. | $324.55 | 2019-2021 | |
| Pfizer INC. | $292.57 | 2023-2025 | |
| Allergan, INC. | $281.86 | 2020 | |
| Ucb, INC. | $262.63 | 2019-2025 | Zilbrysq, Rystiggo |
| Emd Serono, INC. | $191.63 | 2019-2025 | Mavenclad |
| Grifols USA, LLC | $190.58 | 2023-2025 | Gamunex-C |
| Amgen INC. | $188.42 | 2019-2025 | Uplizna |
| Livanova USA, INC. | $183.50 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| W. L. Gore & Associates, INC. | $178.64 | 2019 |
Show all 53 companies
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lin Lemay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.